Synvisc

BY Genzyme (USA)

Founded by Genzyme, an international business of care, specialized on rare diseases, oncology, multiple sclerosis and immunology. SYNVISC® provides rapid and long-lasting relief, with efficacy demonstrated for up to six months for chronic OA knee pain. Clinical studies have shown significant pain reduction as early as one week post-treatment, sustained through 12 months.

select other brand

Ejal Synocrom Seventy Hyal 2000 RenehaVis Pluryal Plenhyage Olidia MONALISA HYAMINO Linerase INFINI iLLUMA HYALGAN CG DiMONO PTx EUFLEXXA EMLA DR.PEEL DIVES DEHYAL+ Curavisc Biovisc AESTHEFILL AESPLLA RRS Skinfill Ialest ReNTox Neotox Zerotox Bienox Hutox Kamomis METOX Letybo Botulax Coretox Neuronox Innotox Nabota Newest Plinest Rich PL SAYPHA CINGAL DERMAHEAL Croma KYBELLA BELOTERO AQUASHINE ALIDYA ALIAXIN AESSOA Lemon Bottle Stylage Supartz Fx Synvisc Teosyal Cytocare Dr cyj hair filler Durolane Ejal40 Ellanse Fillmed GOURI HArmonyCa HYAcorp Jalupro Juvederm Karisma Mesoestetic Neauvia Nithya Nucleofill Orthovisc Perfectha Profhilo Radiesse Restylane Revolax Sculptra

Synvisc® 2 ml

8.0 mg/ml Hylan G-F 20
Syringe 1 x 6.0 ml

Synvisc® 2 mL is an injectable treatment designed to manage and alleviate pain associated with osteoarthritis (OA) of the knee. It contains Hylan G-F 20, a cross-linked polymer that mimics the natural synovial fluid, providing enhanced lubrication and cushioning in the knee joint. The high molecular weight (6 million Daltons) of Hylan G-F 20 offers superior shock absorption, reducing pain and improving joint mobility for patients with OA.

Area of Injection: Intra-articular (knee)
Approval: FDA and CE Mark
Shelf Life: 36 months
Molecular Weight: 6 million Daltons
Source: Chicken combs

Synvisc One® 6 ml

6.0 mg/ml Hylan G-F 20
Syringe 1 x 6.0 ml

Synvisc-One® 6 mL is a single-injection solution designed for the management and alleviation of pain associated with osteoarthritis (OA) of the knee. Containing Hylan G-F 20, it mimics the natural synovial fluid, providing lubrication and cushioning within the knee joint. Synvisc-One is ideal for patients seeking a convenient, single-injection treatment for rapid and sustained relief from OA pain, improving joint mobility and comfort.

Area of Injection: Intra-articular (knee)
Approval: FDA and CE Mark
Shelf Life: 36 months
Molecular Weight: 6 million Daltons
Source: Chicken combs

IS YOUR PRODUCT MISSING FROM OUR RANGE?

Get in touch to hear more about how to become a supplier.

WeChat ID: Bioresus